ArticleOncoTargets and therapy2018

EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials.

Jing-Xun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.